Condition
Parkinson Disease Psychosis clinical trials and research
Research outlook What's coming for Parkinson's disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Parkinson Disease Psychosis clinical trials that are recruiting, at sites in 2 countries (most in South Korea (1), United States (1)). By phase: Phase 1 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Evaluating the safety and tolerability of FB418 in healthy adults and elderly
This study is testing how safe and well-tolerated a new drug called FB418 is in healthy adults and older people by giving them single and multiple doses.
-
Using a PET tracer to study serotonin receptors in neurodegenerative diseases
This study is testing how a new imaging method can help us understand serotonin receptors in people with neurodegenerative diseases like Parkinson's and see if a medication can improve their psychosis symptoms.
Related topics
Quick answers
How many Parkinson Disease Psychosis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.